Kyolic aged garlic extract improves aerobic fitness in middle‑aged recreational endurance athletes: A randomized double‑blind placebo‑controlled 3 month trial

Ried,Karin; Paye,Yeah; Beale,David; Sali,Avni

doi:10.3892/etm.2025.12836

Kyolic aged garlic extract improves aerobic fitness in middle‑aged recreational endurance athletes: A randomized double‑blind placebo‑controlled 3 month trial

Authors:
- Karin Ried
- Yeah Paye
- David Beale
- Avni Sali
View Affiliations

Affiliations: National Institute of Integrative Medicine, Melbourne, Victoria 3122, Australia, Department of Environment, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Brisbane, Queensland 4102, Australia
Published online on: February 26, 2025 https://doi.org/10.3892/etm.2025.12836
Article Number: 86
Copyright: © Ried et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Arterial stiffness is a cardiovascular risk factor that increases with age. Kyolic aged garlic extract has been shown to reduce arterial stiffness, while normalizing blood pressure, cholesterol and blood thickness. The present study hypothesized that increased flexibility of arteries could lead to slower blood flow and increased oxygen uptake and overall aerobic fitness. The present 12 week trial aimed to assess the effect of Kyolic aged garlic extract (AGE) on arterial stiffness, aerobic fitness, lactate threshold, recovery from muscle soreness and cardiovascular proteomic biomarkers in middle‑aged (40‑65 years) endurance athletes with elevated arterial stiffness. A total of 75 middle‑aged recreational endurance athletes completed the trial, after being randomly allocated for 12 weeks to either the placebo or Kyolic aged garlic extract groups: low‑dose cohort 1 (n=37), 2 capsules/day containing 1.2 g AGE powder and 1.2 mg S‑allylcysteine (SAC); and the high‑dose cohort 2 (n=38), 4 capsules/day of 2.4 g AGE powder and 2.4 mg SAC. Arterial stiffness was assessed through pulse wave velocity measurements and aerobic fitness was measured by volume‑maximal‑oxygen‑consumption (VO₂max) and lactate thresholds during high‑intensity exercise using a cycle‑ergometer‑test‑station, as well as measuring the levels of muscle fatigue and recovery time at 12 weeks compared with the baseline results. Urinary proteomic analysis was performed in a subgroup of participants and measured the levels of certain relevant proteins used as biomarkers for risk of cardiovascular events, at 12 weeks compared with baseline results. The Kyolic aged garlic extract group significantly improved their aerobic fitness, as was evidenced by increased VO2max, increased aerobic power, higher lactate threshold‑to‑oxygen uptake, higher lactate threshold‑to‑power output and quicker recovery times compared with the placebo group. Pulse wave velocity, a measure for arterial flexibility, was improved in the Kyolic aged garlic extract group compared with the placebo. The proteomics analysis demonstrated that a subset of polypeptides associated with cardiovascular risk, such as heart attacks and stroke, decreased in the Kyolic aged garlic extract group at 12 weeks compared with the baseline, which was contrary to the effects observed in the placebo group. Therefore, the results of the present study suggested that Kyolic aged garlic extract significantly improved aerobic fitness, lactate threshold, recovery and cardiovascular proteomic biomarkers in middle‑aged endurance athletes within 12 weeks. The present clinical trial was registered on 11/03/2020 at the Australian New Zealand Clinical Trial Registry (trial registration no. ACTRN12620000340932).

View Figures

View References

1	Ried K and Fakler P: Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevance. Integr Blood Press Control. 7:71–82. 2024.PubMed/NCBI View Article : Google Scholar
2	Ried K, Frank OR and Stocks NP: Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: A randomised controlled trial. Maturitas. 67:144–150. 2010.PubMed/NCBI View Article : Google Scholar
3	Ried K, Frank OR and Stocks NP: Aged garlic extract reduces blood pressure in hypertensives: a dose-response trial. Eur J Clin Nutr. 67:64–70. 2013.PubMed/NCBI View Article : Google Scholar
4	Ried K, Travica N and Sali A: The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: the AGE at Heart trial. Integr Blood Press Control. 9:9–21. 2016.PubMed/NCBI View Article : Google Scholar
5	Ried K, Travica N and Sali A: The effect of Kyolic aged garlic extract on gut microbiota, inflammation and cardiovascular health in hypertensives: The GarGIC trial. Frontiers in Nutrition. 5(122)2018.PubMed/NCBI View Article : Google Scholar
6	Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I and Struijker-Boudier H: European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 27:2588–2605. 2006.PubMed/NCBI View Article : Google Scholar
7	Zieman SJ, Melenovsky V and Kass DA: Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 25:932–943. 2005.PubMed/NCBI View Article : Google Scholar
8	Nunan D, Fleming S, Hametner B and Wassertheurer S: Performance of pulse wave velocity measured using a brachial cuff in a community setting. Blood Pressure Monitoring. 19:315–319. 2014.PubMed/NCBI View Article : Google Scholar
9	Lee HY and Oh BH: Aging and arterial stiffness. Circ J. 74:2257–2262. 2010.PubMed/NCBI View Article : Google Scholar
10	Luft FC: Molecular mechanisms of arterial stiffness: New insights. J Am Soc Hypertens. 6:436–438. 2012.PubMed/NCBI View Article : Google Scholar
11	SphygmoCor XCEL, Cardiex USA. Available from: https://cardiex.com/products/sphygmocor-xcel/.
12	Mobil-O-Graph IEM, Germany. Available from: https://www.iem.de/en_US/mobil-o-graph.
13	Nunan D, Wassertheurer S, Lasserson D, Hametner B, Fleming S, Ward A and Heneghan C: Assessment of central haemomodynamics from a brachial cuff in a community setting. BMC Cardiovasc Disord. 12(48)2012.PubMed/NCBI View Article : Google Scholar
14	Weiss W, Gohlisch C, Harsch-Gladisch C, Tölle M, Zidek W and van der Giet M: Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device. Blood Press Monit. 17:128–131. 2012.PubMed/NCBI View Article : Google Scholar
15	Naci H and Ioannidis JP: Comparative effectiveness of exercise and drug interventions on mortality outcomes: Metaepidemiological study. Br J Sports Med. 49:1414–1422. 2015.PubMed/NCBI View Article : Google Scholar
16	Fagard RH: Exercise therapy in hypertensive cardiovascular disease. Prog Cardiovasc Dis. 53:404–411. 2011.PubMed/NCBI View Article : Google Scholar
17	Myers J, Gullestad L, Bellin D, Ross H, Vagelos R and Fowler M: Physical activity patterns and exercise performance in cardiac transplant recipients. J Cardiopulm Rehabil. 23:100–106. 2003.PubMed/NCBI View Article : Google Scholar
18	Bassett DR and Howley ET: Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc. 32:70–84. 2000.PubMed/NCBI View Article : Google Scholar
19	Tanaka H and Seals DR: Endurance exercise performance in Masters athletes: age associated changes and underlying physiological mechanisms. J Physiol. 586:55–63. 2008.PubMed/NCBI View Article : Google Scholar
20	Maffulli N, Testa V and Capasso G: Anaerobic threshold determination in master endurance runners. J Sports Med Phys Fitness. 34:242–249. 1994.PubMed/NCBI
21	Faude O, Kindermann W and Meyer T: Lactate threshold concepts. Sports Med. 39:469–490. 2009.PubMed/NCBI View Article : Google Scholar
22	Abe D, Yoshida T, Ueoka H, Sugiyama K and Fukuoka Y: Relationship between perceived exertion and blood lactate concentrations during incremental running test in young females. BMC Sports Sci Med Rehabil. 7(5)2015.PubMed/NCBI View Article : Google Scholar
23	McCormack HM, David JdL and Sheather S: Clinical applications of visual analogue scales: A critical review. Psychol Med. 18:1007–1019. 1988.PubMed/NCBI View Article : Google Scholar
24	Vaitkevicius PV, Fleg JL, Engel JH, O'Connor FC, Wright JG, Lakatta LE, Yin FC and Lakatta EG: Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation. 88:1456–1462. 1993.PubMed/NCBI View Article : Google Scholar
25	Tanaka H and Seals DR: Invited review: Dynamic exercise performance in masters athletes: Insight into the effects of primary human aging on physiological functional capacity. J Applied Physiol. 95:2152–2162. 2003.PubMed/NCBI View Article : Google Scholar
26	Proctor DN and Joyner MJ: Skeletal muscle mass and the reduction of VO₂max max in trained older subjects. J Appl Physiol. 82:1411–1415. 1997.PubMed/NCBI View Article : Google Scholar
27	Morihara N, Ushijima M, Kashimoto N, Sumioka I, Nishihama T, Hayama M and Takeda H: Aged garlic extract ameliorates physical fatigue. Biol Pharm Bull. 29:962–966. 2006.PubMed/NCBI View Article : Google Scholar
28	Morihara N, Nishihama T, Ushijima M, Ide N, Takeda H and Hayama M: Garlic as an anti-fatigue agent. Mol Nutr Food Res. 51:1329–1334. 2007.PubMed/NCBI View Article : Google Scholar
29	Ushijima M, Sumioka I, Kakimoto M, Yokoyama K, Uda N, Matsuura H, Kyo E, Suzuki A, Kasuga S, Itakura Y, et al: Effect of garlic and garlic preparations on physiological and psychological stress in mice. Phytotherapy Res. 11:226–230. 1997.
30	Ince D, Soenmez G and Ince M: Effects of garlic on aerobic performance. Turkish J Med Sci. 30:557–561. 2000.
31	Womack C, Lawton D, Redmond L, Todd M and Hargens T: The effects of acute garlic supplementation on the fibrinolytic and vasoreactive response to exercise. J Int Soc Sports Nutr. 12(23)2015.PubMed/NCBI View Article : Google Scholar
32	Verma SK, Rajeevan V, Jain P and Bordia A: Effect of garlic (Allium sativum) oil on exercise tolerance in patients with coronary artery disease. Indian J Physiol Pharmacol. 49:115–118. 2005.PubMed/NCBI
33	The-Age: Charles Erasmus, a ‘gentle soul’, loses life just metres from Big Bay Swim finish line. https://www.theage.com.au/national/victoria/charles-erasmus-a-gentle-soul-loses-life-just-metres-from-big-bay-swim-finish-line-20150223-13m3u0.html.
34	ABC-News: Man, 65, dies during Lorne's Pier to Pub open water swim, Victoria. https://www.abc.net.au/news/2019-01-12/man-drowns-during-pier-to-pub-open-water-swim-race/10711120.
35	Zimmerli LU, Schiffer E, Zürbig P, Good DM, Kellmann M, Mouls L, Pitt AR, Coon JJ, Schmieder RE, Peter KH, et al: Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics. 7:290–298. 2008.PubMed/NCBI View Article : Google Scholar
36	Brown CE, McCarthy NS, Hughes AD, Sever P, Stalmach A, Mullen W, Dominiczak AF, Sattar N, Mischak H, Thom S, et al: Urinary proteomic biomarkers to predict cardiovascular events. Proteomics Clin Appl. 9:610–617. 2015.PubMed/NCBI View Article : Google Scholar
37	Delles C, Schiffer E, von Zur Muhlen C, Peter K, Rossing P, Parving HH, Dymott JA, Neisius U, Zimmerli LU, et al: Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals. J Hypertens. 28:2316–2322. 2010.PubMed/NCBI View Article : Google Scholar
38	Silva S, Bronze MR, Figueira ME, Siwy J, Mischak H, Combet E and Mullen W: Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): A randomized, parallel, controlled, double-blind study. Am J Clin Nutr. 101:44–54. 2015.PubMed/NCBI View Article : Google Scholar
39	American-Heart-Association. Target Heart Rate Charts 2024. Available from: https://www.heart.org/en/healthy-living/fitness/fitness-basics/target-heart-rates.
40	Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF and Oja P: International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 35:1381–1395. 2003.PubMed/NCBI View Article : Google Scholar
41	Salvi P, Scalise F, Rovina M, Moretti F, Salvi L, Grillo A, Gao L, Baldi C, Faini A, Furlanis G, et al: Noninvasive estimation of aortic stiffness through different approaches: comparison with intra-aortic recordings. Hypertension. 74:117–129. 2019.PubMed/NCBI View Article : Google Scholar
42	Wassertheurer S, Kropf J, Weber T, Van der Giet M, Baulmann J, Ammer M, Hametner B, Mayer CC, Eber B and Magometschnigg D: A new oscillometric method for pulse wave analysis: Comparison with a common tonometric method. J Hum Hypertens. 24:498–504. 2010.PubMed/NCBI View Article : Google Scholar
43	Kolkenbeck-Ruh A, Soepnel LM, Kim AW, Naidoo S, Smith W, Davies J and Ware LJ: Pulse wave velocity in South African women and children: comparison between the Mobil-O-Graph and SphygmoCor XCEL devices. J Hypertens. 40:65–75. 2022.PubMed/NCBI View Article : Google Scholar
44	Blood Pressure Monitor Omron HEM-907, JA-Davey-Pty-Ltd Australia. Available from: https://www.omronhealthcare-ap.com/au/product/93-hem-907.
45	Abstract 0-13, International Garlic Symposium. Frontiers of garlic research in health promotion and disease prevention. Munich, Germany, 26-28 April 2024. https://garlicsymposium2024.com.